Search research articles
Contact Us
Filters
Showing results (201-210 of 288) with videos related to
Page
of 29
Sort By:
Rheumatology and Therapy
|
March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
The Journal of Rheumatology
|
July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review
Laura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
The Journal of Rheumatology
|
August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers
Barry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.
Rheumatology and Therapy
|
July 2, 2022
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Irish Journal of Medical Science
|
May 12, 2018
Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines
Kieran E Murray, Louise Moore, Celine O'Brien, et al.
Irish Journal of Medical Science
|
May 27, 2019
A multidisciplinary approach to reproductive healthcare in women with rheumatic disease
Kieran Murray, Louise Moore, Celine O'Brien, et al.
RMD Open
|
March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.
Arthritis Research & Therapy
|
December 25, 2013
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder
Emese Balogh, Joao Madruga Dias, Carl Orr, et al.
Proteomics. Clinical Applications
|
June 26, 2015
A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis
Emily S Collins, Aisha Q Butt, David S Gibson, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 288) with videos related to
Sort By:
Page
of 29
Rheumatology and Therapy
|
March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
The Journal of Rheumatology
|
July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review
Laura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
The Journal of Rheumatology
|
August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers
Barry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.
Rheumatology and Therapy
|
July 2, 2022
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Irish Journal of Medical Science
|
May 12, 2018
Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines
Kieran E Murray, Louise Moore, Celine O'Brien, et al.
Irish Journal of Medical Science
|
May 27, 2019
A multidisciplinary approach to reproductive healthcare in women with rheumatic disease
Kieran Murray, Louise Moore, Celine O'Brien, et al.
RMD Open
|
March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.
Arthritis Research & Therapy
|
December 25, 2013
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder
Emese Balogh, Joao Madruga Dias, Carl Orr, et al.
Proteomics. Clinical Applications
|
June 26, 2015
A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis
Emily S Collins, Aisha Q Butt, David S Gibson, et al.
Page
of 29